The prognostic signature based on REG1B, TGM6, NTF4, PNMA5, and HOXC13 could divide colon cancer patients into high–risk and low–risk groups, with an AUC of the ROC of 0.771. This evidence concerns the gene PNMA5 and malignant colon neoplasm.